Philip Morris International Inc. (PMI) has declared a regular quarterly dividend of $1.35 per common share, payable on July 15, 2025, to shareholders of record as of June 27, 2025. The ex-dividend date is also set for June 27, 2025.
As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, with an estimated 38.6 million adults using these products globally. The smoke-free business accounted for 42% of PMI’s first-quarter 2025 total net revenues.
Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products. This investment is aimed at completely ending the sale of cigarettes. The U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s general snus and zyn nicotine pouches, as well as versions of PMI’s iqos devices and consumables, marking the first-ever authorizations in their respective categories.
Moreover, versions of iqos devices and consumables and general snus have obtained the first-ever modified risk tobacco product authorizations from the FDA. PMI also has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences.
In terms of financial performance, PMI's smoke-free business has seen substantial growth, accounting for a significant portion of the company’s total net revenues. The company's continued investment in innovative smoke-free products has led to significant achievements in receiving authorizations and product approvals from regulatory authorities. As a result of these announcements, the company's shares have moved 0.4% on the market, and are now trading at a price of $184.10. Check out the company's full 8-K submission here.
